Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2026-01-07 @ 7:42 AM
Study NCT ID:
NCT00485069
Status:
COMPLETED
Last Update Posted:
2010-12-15
First Post:
2007-06-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2009-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-11
First Submit QC Date:
None
Study First Post Date:
2007-06-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-09-20
Results First Submit QC Date:
None
Results First Post Date:
2010-12-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-08-17
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2010-11-18
Last Update Post Date:
2010-12-15
Last Update Post Date Type:
ESTIMATED